Pentobarbital
Back to searchMolecule Structure
Scientific Name
Pentobarbital
Description of the Drug
Pentobarbital is a barbiturate drug used to induce sleep, cause sedation, and control certain types of seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00312
http://www.drugbank.ca/drugs/DB00312
Brand Name(s)
Nembutal
Company Owner(s)
Vitarine Pharmaceuticals Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Nexgen Pharma Inc, Purepac Pharmaceutical Co, Anabolic Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Akorn Operating Co Llc, Elkins Sinn Div Ah Robins Co Inc, Wyeth Ayerst Laboratories
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL24966 | |||
PharmGKB | PA450859 | |||
Human Metabolome Database | HMDB0014457 | |||
DrugBank | DB00312 | |||
PubChem: Thomson Pharma | 15196098 | |||
PubChem | 4737 | |||
LINCS | LSM-1566 | |||
Nikkaji | J4.552G | |||
BindingDB | 50055935 | |||
EPA CompTox Dashboard | DTXSID7023435 | |||
DrugCentral | 2095 | |||
Guide to Pharmacology | 5480 | |||
rxnorm | PENTOBARBITAL | BEUTHANASIA | PENTOBARBITAL SODIUM | NEMBUTAL |
KEGG Ligand | C07422 | |||
ChEBI | 7983 |